1. Ashmarin, I. P., Nezavibat’ko, V. N., Myasoedov, N. F., et al., “The nootropic adrenocorticotropic hormone 4–10 analog Semax (15 years of experience in development and research),” Zh. Vyssh. Nerv. Deyat., 47, No. 3, 420–430 (1997).
2. Atwal, N., Winters, B. L., and Vaughan, C. W., “Endogenous cannabinoid modulation of restraint stress-induced analgesia in thermal nociception,” J. Neurochem., 152, No. 1, 92–102 (2020).
3. Butler, R. K. and Finn, D. P., “Stress-induced analgesia,” Prog. Neurobiol., 88, No. 3, 184–202 (2009).
4. Catania, A. and Lipton, J. M., “α-Melanocyte stimulating hormone in the modulation of host reactions,” Endocr. Rev., 14, No. 5, 564–576 (1993).
5. Catania, A., Gatti, S., Colombo, G., and Lipton, J. M., “Targeting melanocortin receptors as a novel strategy to control infl ammation,” Pharmacol. Rev., 56, No. 1, 1–29 (2004).